Products in clinical development

Click on the product name to link directly to the product sheet.


  Products Indications Phase 1 Phase 2 Phase 3
Oncology AEZS-112
(oncology)
Solid tumors
Phase 1    
AEZS-108
Ovarian cancer, endometrial cancer
Ovarian and endometrial cancer
  Phase 2  
Perifosine
Multiple myeloma and advanced metastatic colorectal cancer
Multiple myeloma and advanced metastatic colorectal cancer
    Phase 3
Perifosine
Multiple cancers
Colorectal cancer, Kidney cancer and other types of cancer
  Phase 2  
Endocrine Therapy SolorelTM (AEZS-130)
Diagnostic in adult growth hormone deficiency (endocrinology)
Diagnostic test for growth hormone deficiencies
    Phase 3
AEZS-130
Therapeutic in tumor induced cachexia and others (endocrinology)
Therapeutic treatment for growth hormone deficiencies
Phase 1    



Contact

To inquire about partnering opportunities (in- or out-licensing), please contact our business development group:

Chantal Gravel
Director, Business Operations
Phone: (418) 652-8525
cgravel@aezsinc.com